Register | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jyuh's acei [65 articles]

Recent papers added to jyuh's library classified by the tag acei. You can also see everyone's acei.
  • Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
    Journal of hypertension, Vol. 25, No. 10. (October 2007), pp. 2082-2092.
    by V Bhatnagar, DT O'Connor, NJ Schork, RM Salem, CM Nievergelt, BK Rana, DW Smith, GL Bakris, JP Middleton, KC Norris, JT Wright, D Cheek, L Hiremath, G Contreras, LJ Appel, MS Lipkowitz
    posted to snp bp acei ace by jyuh on 2008-08-16 07:54:33 as **
  • Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 23, No. 4. (April 2008), pp. 1274-1277.
    by A Nikzamir, M Nakhjavani, A Esteghamati, A Rashidi
    posted to snp dn acei ace by jyuh on 2008-08-12 08:38:20 as **
  • Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, Vol. 9, No. 1. (March 2008), pp. 1-9.
    by B Gojanovic, F Feihl, L Liaudet, B Waeber
    posted to ccb bp arb acei by jyuh on 2008-07-21 05:49:29 as **
  • Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    The American journal of cardiology, Vol. 100, No. 3A. (6 August 2007)
    by M Böhm
    posted to rct dual cv arb acei by jyuh on 2008-07-21 05:03:00 as **
  • The COOPERATE trial: a letter of concern.
    Lancet, Vol. 371, No. 9624. (10 May 2008), pp. 1575-1576.
    by R Kunz, M Wolbers, T Glass, JF Mann
    posted to rct meta-analysis arb acei by jyuh on 2008-07-21 05:00:41 as **
  • Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
    Lancet, Vol. 361, No. 9352. (11 January 2003), pp. 117-124.
    by N Nakao, A Yoshimura, H Morita, M Takada, T Kayano, T Ideura
    posted to rct dual ckd arb acei by jyuh on 2008-07-21 04:47:08 as **
  • Sex differences in response to chronic heart failure therapies
    Expert Review of Cardiovascular Therapy, Vol. 6, No. 4. (April 2008), pp. 555-565.
    by Ghali, K Jalal, Lindenfeld, Joann
    posted to gender chf arb acei by jyuh on 2008-07-21 04:39:52 as **
  • Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure.
    The American journal of cardiology, Vol. 101, No. 5. (1 March 2008), pp. 639-644.
    by C Tribouilloy, D Rusinaru, L Leborgne, M Peltier, Z Massy, M Slama
    posted to mortality diastolic chf acei by jyuh on 2008-07-21 04:39:14 as **
  • Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy.
    Vascular health and risk management, Vol. 4, No. 1. (2008), pp. 223-234.
    by GL Colombo, M Caruggi, C Ottolini, AP Maggioni
    posted to rct dual cost-effective arb acei by jyuh on 2008-07-21 04:19:24 as **
  • Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 157-163.
    by RA Weir, JJ McMurray, M Puu, SD Solomon, B Olofsson, CB Granger, S Yusuf, EL Michelson, K Swedberg, MA Pfeffer,
    posted to rct dual chf arb acei by jyuh on 2008-07-21 04:10:12 as **
  • Angiotensin-converting enzyme inhibitors and survival in women and men with heart failure.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 9, No. 6-7. (l 2007), pp. 594-601.
    by G Keyhan, SF Chen, L Pilote
    posted to gender chf acei by jyuh on 2008-07-21 03:15:54 as **
  • Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 9, No. 6-7. (l 2007), pp. 602-609.
    by M Hudson, E Rahme, H Behlouli, R Sheppard, L Pilote
    posted to gender chf arb acei by jyuh on 2008-07-21 03:13:15 as **
  • Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.
    Journal of hypertension, Vol. 25, No. 5. (May 2007), pp. 951-958.
    by , F Turnbull, B Neal, M Pfeffer, J Kostis, C Algert, M Woodward, J Chalmers, A Zanchetti, S MacMahon
    posted to cv bp arb acei by jyuh on 2008-07-21 02:08:23 as **
  • Targeting cardiovascular protection: the concept of dual renin-angiotensin system control.
    Medscape journal of medicine, Vol. 10 Suppl (2008)
    by T Unger, A Jakobsen, J Heroys, A Ralph, T Rees, M Shaw
    posted to dual arb acei by jyuh on 2008-07-21 02:01:04 as **
  • Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Journal of hypertension, Vol. 26, No. 7. (July 2008), pp. 1282-1289.
    by Gianpaolo Reboldi, Fabio Angeli, Claudio Cavallini, Giorgio Gentile, Giuseppe Mancia, Paolo Verdecchia
    posted to stroke mortality meta-analysis cv arb acei by jyuh on 2008-07-21 01:49:35 as **
  • Ace inhibitors as a therapy for sarcopenia - evidence and possible mechanisms.
    The journal of nutrition, health & aging, Vol. 12, No. 7. (July 2008), pp. 480-485.
    by D Sumukadas, MD Witham, AD Struthers, ME McMurdo
    posted to cachexia acei by jyuh on 2008-07-21 01:48:30 as **
  • Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.
    The Canadian journal of cardiology, Vol. 24, No. 6. (June 2008), pp. 491-496.
    by DM Rabi, N Khan, M Vallee, MA Hladunewich, SW Tobe, L Pilote
    posted to rct gender arb acei by jyuh on 2008-07-20 15:56:27 as **
  • RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
    Clinical research in cardiology : official journal of the German Cardiac Society, Vol. 97, No. 7. (July 2008), pp. 418-431.
    by C Werner, M Baumhäkel, KK Teo, R Schmieder, J Mann, T Unger, S Yusuf, M Böhm
    posted to dual arb acei by jyuh on 2008-07-20 15:55:07 as **
  • Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
    Postgraduate medicine, Vol. 120, No. 1. (April 2008), pp. 33-42.
    by GL Bakris, MR Weir
    posted to dual ckd arb acei by jyuh on 2008-07-20 15:17:06 as **
  • Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
    Journal of cardiac failure, Vol. 14, No. 3. (April 2008), pp. 181-188.
    by R Lakhdar, MH Al-Mallah, DE Lanfear
    posted to meta-analysis dual cv arb acei by jyuh on 2008-07-20 15:06:28 as **
  • Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
    Cancer, Vol. 112, No. 4. (15 February 2008), pp. 748-757.
    by R van der Knaap, C Siemes, JW Coebergh, CM van Duijn, A Hofman, BH Stricker
    posted to cancer arb acei by jyuh on 2008-07-14 11:32:31 as **
  • Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.
    American journal of physiology. Renal physiology, Vol. 284, No. 4. (April 2003)
    by R Agarwal
    posted to ros inflammation ckd arb acei by jyuh on 2008-07-08 04:19:33 as **
  • Soluble adhesion molecules in end-stage renal disease: a predictor of outcome.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 21, No. 6. (June 2006), pp. 1603-1610.
    by ME Suliman, AR Qureshi, O Heimbürger, B Lindholm, P Stenvinkel
    posted to inflammation hd acei by jyuh on 2008-07-05 10:48:34 as **
  • Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure?
    Journal of internal medicine, Vol. 246, No. 5. (November 1999), pp. 503-507.
    by P Stenvinkel, P Andersson, T Wang, B Lindholm, J Bergström, J Palmblad, O Heimbürger, T Cederholm
    posted to inflammation ckd acei by jyuh on 2008-07-05 10:43:49 as **
  • Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
    Kidney international, Vol. 70, No. 7. (October 2006), pp. 1318-1324.
    by F Zannad, M Kessler, P Lehert, JP Grünfeld, C Thuilliez, A Leizorovicz, P Lechat
    posted to rct mortality hd acei by jyuh on 2008-07-04 14:35:27 as **
  • Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 22, No. 12. (December 2007), pp. 3573-3579.
    by M Kessler, F Zannad, P Lehert, JP Grünfeld, C Thuilliez, A Leizorovicz, P Lechat,
    posted to hd cv acei by jyuh on 2008-07-04 14:28:21 as **
  • Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (20 June 2008)
    by Wei Fang, Dimitrios G G Oreopoulos, Joanne M M Bargman
    posted to pd mortality arb acei by jyuh on 2008-07-01 03:39:38 as **
  • Sarcopenia--a potential target for Angiotensin-converting enzyme inhibition?
    Gerontology, Vol. 52, No. 4. (2006), pp. 237-242.
    by D Sumukadas, AD Struthers, ME McMurdo
    posted to sarcopenia acei by jyuh on 2008-06-29 01:46:38 as **
  • Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial
    CMAJ, Vol. 177, No. 8. (9 October 2007), pp. 867-874.
    by Deepa Sumukadas, Miles D Witham, Allan D Struthers, Marion E Mcmurdo
    posted to sarcopenia geriatric acei by jyuh on 2008-06-29 01:12:00 as **
  • ACE inhibitors for sarcopenia--as good as exercise training?
    Age and ageing (30 May 2008)
    by Miles D D Witham, Deepa Sumukadas, Marion E T E McMurdo
    posted to sarcopenia acei by jyuh on 2008-06-29 01:06:34 as **
  • Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study.
    The American journal of clinical nutrition, Vol. 82, No. 2. (August 2005), pp. 428-434.
    by M Cesari, SB Kritchevsky, RN Baumgartner, HH Atkinson, BW Penninx, L Lenchik, SL Palla, WT Ambrosius, RP Tracy, M Pahor
    posted to obesity inflammation cv acei by jyuh on 2008-06-29 00:51:00 as **
  • Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Clinical journal of the American Society of Nephrology : CJASN, Vol. 2, No. 3. (May 2007), pp. 461-469.
    by LH Ficociello, BA Perkins, KH Silva, DM Finkelstein, H Ignatowska-Switalska, Z Gaciong, LA Cupples, A Aschengrau, JH Warram, AS Krolewski
    posted to proteinuria dn acei by jyuh on 2008-06-16 05:32:42 as **
  • Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial
    J Am Soc Nephrol, Vol. 17, No. 12. (1 December 2006), pp. 3472-3481.
    by Piero Ruggenenti, Annalisa Perna, Maria Ganeva, Bogdan Ene-Iordache, Giuseppe Remuzzi, For
    posted to bp rct proteinuria dn acei by jyuh on 2008-06-14 07:30:28 as **
  • Review: the renoprotective effects of ACE inhibitors and ARBs independent of blood pressure control are uncertain
    Evid Based Med, Vol. 11, No. 5. (1 October 2006), 145.
    by Catherine Clase, Amit X Garg
    posted to ckd arb acei by jyuh on 2008-06-12 05:36:34 as **
  • Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    American heart journal, Vol. 155, No. 5. (May 2008), pp. 791-805.
    by S Balamuthusamy, L Srinivasan, M Verma, S Adigopula, N Jalandara, S Hathiwala, E Smith
    posted to cv ckd arb acei by jyuh on 2008-05-22 09:49:36 as **
  • Antiproteinuric Response to Dual Blockade of the Renin-Angiotensin System in Primary Glomerulonephritis: Meta-analysis and Metaregression
    American Journal of Kidney Diseases, Vol. In Press, Corrected Proof
    by Fausta Catapano, Paolo Chiodini, Luca D Nicola, Roberto Minutolo, Pasquale Zamboli, Ciro Gallo, Giuseppe Conte
    posted to gn dual arb acei by jyuh on 2008-05-16 14:35:34 as **
  • Prevention of type 2 diabetes mellitus with angiotensin-converting-enzyme inhibitors.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, Vol. 65, No. 10. (15 May 2008), pp. 935-940.
    by LV Solski, DS Longyhore
    posted to dm acei by jyuh on 2008-05-12 02:26:43 as **
  • Comparative effectiveness of angiotensin-converting-enzyme inhibitors: is an ACE always an ace?
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, Vol. 178, No. 10. (6 May 2008), pp. 1316-1319.
    by AF Hernandez, RA Harrington
    posted to acei by jyuh on 2008-05-09 10:47:55 as **
  • Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers
    Nephrol. Dial. Transplant. (8 May 2008), gfn239.
    by Tomas Berl
    posted to ckd arb acei by jyuh on 2008-05-09 04:36:33 as **
  • Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure
    CMAJ, Vol. 178, No. 10. (6 May 2008), pp. 1303-1311.
    by Louise Pilote, Michal Abrahamowicz, Mark Eisenberg, Karin Humphries, Hassan Behlouli, Jack V Tu
    posted to chf aging acei by jyuh on 2008-05-06 03:31:40 as **
  • Treatment of hypertension in patients 80 years of age or older.
    The New England journal of medicine, Vol. 358, No. 18. (1 May 2008), pp. 1887-1898.
    by NS Beckett, R Peters, AE Fletcher, JA Staessen, L Liu, D Dumitrascu, V Stoyanovsky, RL Antikainen, Y Nikitin, C Anderson, A Belhani, F Forette, C Rajkumar, L Thijs, W Banya, CJ Bulpitt,
    posted to bp rct aging acei by jyuh on 2008-05-06 03:28:08 as **
  • Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (17 April 2008)
    by Leszek Tylicki, Przemysław Rutkowski, Marcin Renke, Wojciech Larczyński, Ewa Aleksandrowicz, Wiesława Lysiak-Szydlowska, Bolesław Rutkowski
    posted to rct ckd arb acei by jyuh on 2008-04-29 03:55:18 as **
  • Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, Vol. 27, No. 4. (g 2007), pp. 446-453.
    by I Kolesnyk, FW Dekker, M Noordzij, S le Cessie, DG Struijk, RT Krediet
    posted to pd arb acei by jyuh on 2008-04-17 10:27:43 as **
  • Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events.
    The New England journal of medicine (31 March 2008)
    by
    posted to rct dual cv arb acei by jyuh on 2008-04-14 03:34:40 as ** along with 2 people djmonstermo byrdjb
  • ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes
    Diabetes, Vol. 57, No. 4. (1 April 2008), pp. 1018-1025.
    by Chris Tikellis, Katarzyna Bialkowski, Josepha Pete, Karen Sheehy, Qui Su, Colin Johnston, Mark E Cooper, Merlin C Thomas
    posted to dn acei ace2 by jyuh on 2008-03-31 11:19:36 as **
  • Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Eur J Endocrinol, Vol. 158, No. 3. (1 March 2008), pp. 317-322.
    by Gang Wang, Fernand M Lai, Ka-Bik Lai, Kai-Ming Chow, Bonnie C Kwan, Philip K Li, Cheuk-Chun Szeto
    posted to urine podocyte dn arb acei by jyuh on 2008-03-23 03:26:52 as **
  • Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
    Kidney Int (19 March 2008)
    by G L L Bakris, R D D Toto, P A A McCullough, R Rocha, D Purkayastha, P Davis
    posted to proteinuria dn diuretics ccb acei by jyuh on 2008-03-22 03:15:36 as **
  • WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
    Cochrane Database Syst Rev, No. 1. (2006)
    by HG Lovell
    posted to proteinuria dm acei by jyuh on 2008-02-14 08:43:29 as **
  • Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
    J Am Soc Nephrol, Vol. 17, No. 12 Suppl 3. (December 2006)
    by SG de Vinuesa, M Goicoechea, J Kanter, M Puerta, V Cachofeiro, V Lahera, F Gómez-Campderá, J Luño
    posted to irs inflammation ckd adipokine acei by jyuh on 2008-01-24 04:22:54 as ** along with 1 person yavanna
  • Rationale for Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor Treatment and End-Organ Protection in Patients with Chronic Kidney Disease.
    Am J Nephrol, Vol. 28, No. 3. (12 December 2007), pp. 372-380.
    by Robert Toto, Biff F F Palmer
    posted to dual ckd arb acei by jyuh on 2008-01-20 04:16:28 as **
    • Note: You may cite this page as: http://www.citeulike.org/user/jyuh/tag/acei

    Result page: 1 2 Next RIS BibTeX